Microbial-isolate identification and testing IVDs

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Achète-le

Disponible depuis:

Biomerieux Australia Pty Ltd

classe:

Class 2

Fabriqué par:

bioMerieux Inc 100 Rodolphe Street, Durham, NC, 27712 United States Of America

Domaine thérapeutique:

CT1261 - Microbial-isolate identification and testing IVDs

indications thérapeutiques:

IVDs intended to be used in testing to provide information about the specific in vitro characteristics and/or identification of microorganisms including bacteria, yeast, fungi, viruses and parasites that have been isolated from a clinical specimen.

Statut de autorisation:

A

Date de l'autorisation:

2013-09-26

Rechercher des alertes liées à ce produit